Candidates like these are currently interviewing for placements for this January’s H2BB cohort. Don't miss out on the best and brightest business talent!

Co-op students for January internships are already securing positions. OBIO H2BB can help connect you to top tier talent from programs with January internships including McMaster’s Master of Biomedical Discovery and Commercialization, University of Toronto’s Master of Biotechnology and McMaster’s DeGroote Co-op MBA. Students from these programs may qualify for Ontario’s Co-operative Education Tax Credit.

This week, as part of the TCI Network 2018 Global Conference, OBIO CEO Gail Garland led a session with Canadian and international experts on our domestic health cluster.

In response to industry demand, OBIO is proud to announce the launch of the OBIO Job Board, its latest ‘Access to Talent’ program. 

The OBIO Job Board will be hosted on the newly revamped OBIO website and will be free for all health science companies wishing to post their latest health science job openings. 

If you are considering hiring a new graduate or intern this coming January, it is a good idea to get started now. OBIO H2BB is constantly sourcing new early career talent from top business and innovation programs.

OBIO H2BB is now offering top graduate-level, business-trained students and recent graduates, who will expand your business, marketing and/or finance strategies through market research, investor targeting, or conference preparation.

On June 14th, get behind-the-scenes on the recent changes at the FDA and learn more about how regulatory process changes affect your company.

Canada’s premiere innovation and commercialization event for medical device professionals, co-hosted by Starfish Medical and OBIO, Medical Device Playbook 2018 is coming to the MaRS Discovery District on May 8, 2018.

This week, in Part 2 of a blog that began last week, we review the Niagara Emerging Health Science Company Forum, held in Niagara-on-the-Lake on Feb 1-2, 2018.

The forum brought together CEOs and senior executives from high potential Canadian health science companies with senior leadership from American investors and strategics in beautiful Niagara-on-the-Lake for two days of panel presentations, executive roundtables, and networking dinners.

OBIO is working to develop a model that will advance early access to the Ontario market. Critical to the development of this initiative is the ability to quantify the Ontario health science technology pipeline by category and stage of readiness to address the barriers to market access.

Michael Greeley, Co-Founder and General Partner at Flare Capital Partners, an early stage healthcare technology venture firm, and a Founding General Partner Flybridge Capital Partners blogged about Ontario's Health Tech Scene. Michael was a panelist at OBIO's recent Niagara on the Lake Health Sciences Emerging Company Forum, and wrote about his overall impression of the Ontario's emerging health tech companies.

OBIO CAAP® is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with mentoring, strategic guidance and access to an expansive network of health science industry experts and investors to enhance the ability of OBIO CAAP companies to secure financing.

On November 27, 2017, OBIO hosted keynote speaker Dr. Edward Abrahams, President of the Personalized Medicine Coalition, at its 9th Annual Public Meeting at Norton Rose Fulbright LLP and launched OBIO's latest report, "Bridging the Talent Gap"

On November 27th, as part of OBIO's Annual Public Meeting, OBIO will be launching our latest report, Bridging the Talent Gap, on the unique value of OBIO’s Health to Business Bridge (H2BB™) business internship program in 2017.